Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib Post-Transplant for Ph+ Leukemias
NCT00244829Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), sponsored by Fred Hutchinson Cancer Center. Started Jan 2004; status: completed.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00244829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244829.